Development of a novel kit for reduction of aerosolized particles during endonasal surgeries: the pharynvac device
Active Project Grant Awarded Last action
- Award ID
- R41EB035980
- Recipient
-
Pharynvac Surgical Technology Inc. UEI FH8CFJVGU9G4
- Awarding agency
-
National Institute of Biomedical Imaging and Bioenginering
National Institutes of Health, Department of Health and Human Services
- Obligated
- $571,410
Award facts
- Assistance listing
- 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health
- Completion date 98% complete
- Originally
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Description
- Abstract
- Sinonasal surgery is extremely common (>600,000 outpatient procedures annually). There are three issues that can be mitigated with a single device: surgical staff pathogen and toxin exposure, patient blood ingestion, and periodic obstructed endoscopic visualization. Only blood ingestion has a current solution: packing the pharynx with absorbent materials with regular associated adverse events. Here we propose the further development of pharynvac, a balloon aspiration catheter that simultaneously addresses all three of these problems passively. If successful, pharynvac will decrease surgical staff exposure, reduce post-procedure nausea, and minimize operative times, potentially becoming a standard sinonasal surgical tool. This phase i application would allow for the implementation of GMP (SA1), demonstrated blood and particle aspiration in a BIO-realistic oral/nasal model (SA2), and demonstrated device safety/feasibility in a large-animal sheep model (SA3). At this point, pharynvac will move into phase II: FDA engagement and first-in-human clinical trials.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $285,705 | |
| Original award | $285,705 |
Quick answers
Who received award R41EB035980?
R41EB035980 was awarded to Pharynvac Surgical Technology Inc. by National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health) on September 1, 2024.
How much is award R41EB035980 worth?
$571,410 has been obligated on R41EB035980.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award